“…For RNAi experiments, cells were transfected with 50 nM siRNAs (Qiagen, Hilden, Germany or Microsynth, Balgach, Switzerland) for 72 h using Oligofectamine (Invitrogen) or Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions. The target sequences of double-stranded RNA used in this study were as follows: siControl, 59-GGACCTGGAGGTCTGCTGT-39 (McHedlishvili et al, 2012); siCENP-A, 59-AACACAGTCGGCGGAGACAAG-39 (Carroll et al, 2009);siHJURP, 59-CTACTGGGCTCAACTGCAA-39 (Dunleavy et al, 2009); siCUL4A, 59-AAGAATCCTACTGCTGATCGA-39 (Piwko et al, 2010); siCUL4B, 59-CACCGTCTCTAGCTTTGCTAA-39 (Piwko et al, 2010); siDDB1, 59-CCACTAGATCGCGATAATAAA-39 (Piwko et al, 2010); siRBBP7, 59-GCGGATAAGACCGTAGCTTTA-39 (Piwko et al, 2010); siRBBP4, 59-GCCACTCAGTTGATGCTCA-39 (Hayashi et al, 2004); siCDC20, 59-AACCTTGTGGATTGGAGTTCT-39 (Piwko et al, 2010); and siMAD2L1, 59-CAGAAAGCTATCCAGG-ATGAA-39 (Piwko et al, 2010). Cells were synchronized at the G1/S transition by 16 h incubation in 2 mM thymidine (Sigma, St. Louis, MO), washed twice with pre-warmed phosphate-buffered saline (PBS) solution, incubated for 9 h in culture medium and then incubated for another 16 h in 2 mM thymidine.…”